Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sauflon Pharmaceuticals was a British medical device/pharma company specializing in the manufacture of soft contact lenses—including advanced daily disposable silicone hydrogels—and ophthalmic aftercare solutions. Founded by Alan Wells in Twickenham in 1985, it grew rapidly across Europe and globally thanks to patented cost-effective SiH lens production technology, opening a major plant in Budapest with Bond Capital Partners' support. By the time it was acquired by The Cooper Companies for $1.2B USD in August 2014, it had become one of only four companies worldwide making both contact lenses and their associated cleaning/care products, selling into more than fifty markets via sales offices across fourteen countries. All operations are now fully integrated into the parent company’s eye health division under the “CooperVision” brand name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sauflon Pharmaceuticals.